Largest health care companies by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
UnitedHealth Group leads the 170 health care companies ranked by total assets, at CHF 260.7B, ahead of CVS Health (CHF 213.5B) and Pfizer (CHF 175.3B). Figures as of 19 Nov 2026, 09:25 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- UnitedHealth GroupCHF 260.7B
- Median
- CHF 5.3B
- Combined market value
- CHF 7.66T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Ionis PharmaceuticalsIONS · Health Care | CHF 3B | CHF 3.8B | CHF 23.07 | 1.59% up | 64% down | ||
| 102 | Option Care HealthOPCH · Health Care | CHF 2.9B | CHF 4B | CHF 26.71 | 0.25% up | 14% up | ||
| 103 | HealthEquityHQY · Health Care | CHF 2.8B | CHF 6.8B | CHF 81.96 | 4.45% down | 2% down | ||
| 104 | IDEXX LaboratoriesIDXX · Health Care | CHF 2.8B | CHF 46.3B | CHF 588.27 | 1.19% up | 1% down | ||
| 105 | InsuletPODD · Health Care | CHF 2.7B | CHF 8.2B | CHF 117.89 | 3.69% down | 58% down | ||
| 106 | VaxcytePCVX · Health Care | CHF 2.5B | CHF 7.8B | CHF 49.29 | 1.48% down | 22% up | ||
| 107 | RepligenRGEN · Health Care | CHF 2.5B | CHF 9.3B | CHF 145.43 | 6.47% up | 5% up | ||
| 108 | GRAILGRAL · Health Care | CHF 2.5B | CHF 3.9B | CHF 85.99 | 3.57% down | 20% up | ||
| 109 | PTC TherapeuticsPTCT · Health Care | CHF 2.4B | CHF 4.2B | CHF 50.73 | 0.22% down | 20% down | ||
| 110 | Concentra Group Holdings ParentCON · Health Care | CHF 2.4B | CHF 4.4B | CHF 35.36 | 0.94% down | 120% up | ||
| 111 | ExelixisEXEL · Health Care | CHF 2.4B | CHF 14B | CHF 57.52 | 0.31% down | 63% up | ||
| 112 | Merit Medical SystemsMMSI · Health Care | CHF 2.3B | CHF 4.3B | CHF 72.37 | 1.70% up | 1% up | ||
| 113 | LivaNovaLIVN · Health Care | CHF 2.2B | CHF 4.4B | CHF 79.62 | 2.85% up | 71% up | ||
| 114 | Bio-TechneTECH · Health Care | CHF 2.2B | CHF 9.6B | CHF 61.27 | 0.17% up | 26% up | ||
| 115 | MSA SafetyMSA · Health Care | CHF 2.2B | CHF 5.8B | CHF 149.45 | 2.67% up | 11% up | ||
| 116 | Halozyme TherapeuticsHALO · Health Care | CHF 2.1B | CHF 9.2B | CHF 80.68 | 0.18% down | 37% up | ||
| 117 | AlkermesALKS · Health Care | CHF 2.1B | CHF 6.6B | CHF 39.46 | 3.08% up | 58% up | ||
| 118 | NateraNTRA · Health Care | CHF 2B | CHF 35.4B | CHF 243.82 | 0.71% up | 32% up | ||
| 119 | HaemoneticsHAE · Health Care | CHF 2B | CHF 4.7B | CHF 103.48 | 1.60% up | 61% up | ||
| 120 | Revolution MedicinesRVMD · Health Care | CHF 2B | CHF 29.1B | CHF 134.60 | 1.76% down | 131% up | ||
| 121 | CRISPR TherapeuticsCRSP · Health Care | CHF 1.9B | CHF 3.3B | CHF 33.85 | 0.10% up | 21% down | ||
| 122 | InsmedINSM · Health Care | CHF 1.9B | CHF 22.1B | CHF 100.90 | 1.69% down | 40% down | ||
| 123 | Lantheus HoldingsLNTH · Health Care | CHF 1.9B | CHF 5.6B | CHF 85.91 | 0.20% up | 93% up | ||
| 124 | LifeStance Health GroupLFST · Health Care | CHF 1.9B | CHF 4.4B | CHF 11.60 | 2.82% down | 129% up | ||
| 125 | Hims & Hers HealthHIMS · Health Care | CHF 1.8B | CHF 3.4B | CHF 14.36 | 2.85% down | 51% down | ||
| 126 | Guardant HealthGH · Health Care | CHF 1.7B | CHF 16.5B | CHF 122.24 | 1.30% up | 44% up | ||
| 127 | Medpace HoldingsMEDP · Health Care | CHF 1.7B | CHF 15.2B | CHF 544.81 | 0.95% down | 10% up | ||
| 128 | PenumbraPEN · Health Care | CHF 1.5B | CHF 10.6B | CHF 270.02 | 0.47% up | 13% up | ||
| 129 | Kymera TherapeuticsKYMR · Health Care | CHF 1.5B | CHF 8.7B | CHF 102.02 | 0.32% down | 87% up | ||
| 130 | Legend BiotechLEGN · Health Care | CHF 1.5B | CHF 2.7B | CHF 13.69 | 0.87% up | 42% down | ||
| 131 | Ligand PharmaceuticalsLGND · Health Care | CHF 1.3B | CHF 5B | CHF 251.58 | 1.67% up | 43% up | ||
| 132 | ChemedCHE · Health Care | CHF 1.3B | CHF 6B | CHF 460.46 | 0.01% down | 27% up | ||
| 133 | Ascendis PharmaASND · Health Care | CHF 1.2B | CHF 14.9B | CHF 227.68 | 0.32% down | 28% up | ||
| 134 | CytokineticsCYTK · Health Care | CHF 1.2B | CHF 6B | CHF 43.22 | 0.64% down | 20% down | ||
| 135 | Arrowhead PharmaceuticalsARWR · Health Care | CHF 1.2B | CHF 5.1B | CHF 36.31 | 0.28% up | 10% up | ||
| 136 | Krystal BiotechKRYS · Health Care | CHF 1.1B | CHF 7.9B | CHF 265.59 | 5.62% up | 46% up | ||
| 137 | Madrigal PharmaceuticalsMDGL · Health Care | CHF 1.1B | CHF 7.8B | CHF 335.27 | 5.67% down | 24% down | ||
| 138 | Caris Life SciencesCAI · Health Care | CHF 948.1M | CHF 4.7B | CHF 16.42 | 2.21% down | 17% down | ||
| 139 | TG TherapeuticsTGTX · Health Care | CHF 895.5M | CHF 8.4B | CHF 55.69 | 5.44% up | 107% up | ||
| 140 | 10x GenomicsTXG · Health Care | CHF 877.1M | CHF 6.3B | CHF 48.07 | 1.37% up | 260% up | ||
| 141 | ImmunovantIMVT · Health Care | CHF 806M | CHF 5.8B | CHF 27.94 | 0.12% down | 43% up | ||
| 142 | Praxis Precision MedicinesPRAX · Health Care | CHF 789.9M | CHF 7.2B | CHF 257.04 | 0.04% up | 61% up | ||
| 143 | Cogent BiosciencesCOGT · Health Care | CHF 789.7M | CHF 4.1B | CHF 23.42 | 0.14% down | 20% down | ||
| 144 | BridgeBio PharmaBBIO · Health Care | CHF 788.3M | CHF 12.8B | CHF 65.70 | 1.58% up | 17% up | ||
| 145 | GlaukosGKOS · Health Care | CHF 752.5M | CHF 11.6B | CHF 196.30 | 4.18% down | 152% up | ||
| 146 | Mirum PharmaceuticalsMIRM · Health Care | CHF 709.8M | CHF 5.1B | CHF 77.90 | 0.59% up | 31% up | ||
| 147 | Corcept TherapeuticsCORT · Health Care | CHF 704.6M | CHF 6.2B | CHF 57.09 | 3.25% down | 8% down | ||
| 148 | CG OncologyCGON · Health Care | CHF 666.7M | CHF 6B | CHF 67.38 | 1.34% up | 85% up | ||
| 149 | Belite BioBLTE · Health Care | CHF 657.4M | CHF 5.3B | CHF 131.58 | 0.94% down | 31% up | ||
| 150 | Spyre TherapeuticsSYRE · Health Care | CHF 655.1M | CHF 8.1B | CHF 85.45 | 8.15% up | 286% up | ||
| 151 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CHF 643.1M | CHF 6.3B | CHF 80.05 | 0.06% down | 126% up | ||
| 152 | Summit TherapeuticsSMMT · Health Care | CHF 632.7M | CHF 7.1B | CHF 8.84 | 1.59% down | 36% down | ||
| 153 | Axsome TherapeuticsAXSM · Health Care | CHF 581M | CHF 5.9B | CHF 112.86 | 1.43% down | 7% down | ||
| 154 | Protagonist TherapeuticsPTGX · Health Care | CHF 562.8M | CHF 7B | CHF 107.10 | 2.00% up | 46% up | ||
| 155 | ABIVAXABVX · Health Care | CHF 546M | CHF 6.2B | CHF 70.60 | 2.11% up | 27% down | ||
| 156 | Twist BioscienceTWST · Health Care | CHF 540.6M | CHF 6.7B | CHF 97.99 | 3.88% up | 340% up | ||
| 157 | BillionToOneBLLN · Health Care | CHF 532.8M | CHF 3.7B | CHF 77.10 | 6.11% down | 0% up | ||
| 158 | Travere TherapeuticsTVTX · Health Care | CHF 509.7M | CHF 4.1B | CHF 42.31 | 1.68% down | 44% up | ||
| 159 | Edgewise TherapeuticsEWTX · Health Care | CHF 465.4M | CHF 3.8B | CHF 34.84 | 1.59% down | 88% up | ||
| 160 | Dianthus TherapeuticsDNTH · Health Care | CHF 447.2M | CHF 4B | CHF 70.73 | 3.45% down | 113% up | ||
| 161 | Adaptive BiotechnologiesADPT · Health Care | CHF 431.8M | CHF 3.9B | CHF 23.97 | 0.11% down | 88% up | ||
| 162 | ImmunityBioIBRX · Health Care | CHF 422.7M | CHF 6B | CHF 5.64 | 7.03% up | 193% up | ||
| 163 | Oruka TherapeuticsORKA · Health Care | CHF 411.5M | CHF 5.5B | CHF 80.63 | 0.60% down | 241% up | ||
| 164 | Rhythm PharmaceuticalsRYTM · Health Care | CHF 404.4M | CHF 7B | CHF 100.26 | 2.08% up | 13% up | ||
| 165 | Definium TherapeuticsDFTX · Health Care | CHF 370.7M | CHF 3.4B | CHF 24.53 | 0.88% down | 169% up | ||
| 166 | Scholar Rock HoldingSRRK · Health Care | CHF 340.5M | CHF 4.9B | CHF 40.43 | 6.48% up | 14% up | ||
| 167 | ErascaERAS · Health Care | CHF 333.6M | CHF 4.1B | CHF 11.59 | 0.94% down | 403% up | ||
| 168 | HeartflowHTFL · Health Care | CHF 302.7M | CHF 3.4B | CHF 38.65 | 2.51% down | 73% up | ||
| 169 | Kodiak SciencesKOD · Health Care | CHF 296.1M | CHF 5.4B | CHF 82.38 | 1.04% up | 396% up | ||
| 170 | VeradermicsMANE · Health Care | CHF 128.5M | CHF 4.4B | CHF 105.16 | 0.62% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8422 CHF).
Questions and answers
Which health care companies rank first by total assets?
UnitedHealth Group (CHF 260.7B), CVS Health (CHF 213.5B) and Pfizer (CHF 175.3B) are the top three of the 170 health care companies ranked by total assets as of 19 Nov 2026, 09:25 UTC.
How many health care companies are in this ranking?
170 are ranked by total assets.
What are these health care companies worth together?
The 170 health care companies ranked by total assets have a combined market value of CHF 7.66T as of 19 Nov 2026, 09:25 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care companies by total assets”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.